Exercise as adjunctive therapy for systemic lupus erythematosus.

Area of Science:

• Rheumatology
• Autoimmune Diseases
• Exercise Physiology

Background:

• Systemic lupus erythematosus (SLE) is a rare, chronic autoimmune disease affecting millions globally.
• SLE commonly causes fatigue, joint pain, and organ involvement.
• Structured exercise is being explored as an adjunctive therapy for SLE management.

Approach:

• A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
• Searched for studies comparing structured exercise with placebo, usual care, or other non-pharmacological treatments.
• Evaluated outcomes including fatigue, functional capacity, disease activity, quality of life, pain, and adverse events.

Key Points:

• Included 13 studies with 540 participants; most studies had high risk of bias.
• Exercise showed little to no effect on fatigue, functional capacity, and pain compared to placebo or usual care (low-certainty evidence).
• Exercise may slightly reduce fatigue and improve functional capacity compared to non-pharmacological interventions like relaxation therapy (low-certainty evidence).

Conclusions:

• Due to low-certainty evidence, the benefits of exercise for SLE patients remain uncertain.
• More high-quality research is needed to confirm the efficacy and safety of exercise in SLE management.
• Harms associated with exercise in SLE patients were not well-reported in the included studies.